Caris Life Sciences, Inc. (CAI)

Caris Life Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	105.14	-68.09	-281.89	-341.42	-320.83
Depreciation & Amortization	20.76	22.62	48.91	49	48.25
Other Amortization	5.99	12.77	7.05	5.38	2.65
Stock-Based Compensation	65.11	70.01	18.64	15.24	22.9
Other Operating Activities	34.65	78.98	-8.85	2.82	-16.43
Change in Accounts Receivable	-71.58	-29.79	-33.82	-15.08	-11.91
Change in Inventory	-79.77	-20.75	5.46	-4.44	-11.1
Change in Accounts Payable	52.59	11.04	-0.23	7.17	8.91
Change in Other Net Operating Assets	35.66	6.38	-0.48	5.22	-8.16
Operating Cash Flow	168.56	83.16	-245.2	-276.1	-285.71
Operating Cash Flow Growth	-	-	-	-	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Capital Expenditures	-44.6	-16.26	-8.44	-22.32	-42.26
Investment in Securities	-100.12	-	61.38	237.09	-240.73
Investing Cash Flow	-144.72	-16.26	52.93	214.77	-282.99

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Long-Term Debt Issued	-	27.87	199.98	191.31	-
Long-Term Debt Repaid	-	-0.11	-0.16	-180.74	-0.96
Net Debt Issued (Repaid)	-12.95	27.76	199.82	10.57	-0.96
Issuance of Common Stock	9.61	536.1	1.53	1.87	11.41
Repurchase of Common Stock	-43.67	-18.66	-	-	-
Other Financing Activities	-6.77	-1.44	-1.06	-2.3	-
Financing Cash Flow	-53.78	664.99	200.29	10.13	10.45

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Foreign Exchange Rate Adjustments	-0	0.13	-0	0.06	0
Net Cash Flow	-29.94	732.01	8.02	-51.13	-558.25

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Free Cash Flow	123.96	66.9	-253.64	-298.42	-327.96
Free Cash Flow Growth	-	-	-	-	-
Free Cash Flow Margin	12.53%	8.24%	-61.52%	-97.48%	-126.88%
Free Cash Flow Per Share	0.44	0.40	-7.15	-8.54	-9.83
Levered Free Cash Flow	63.26	53.5	-143.65	-178.04	-
Unlevered Free Cash Flow	86.58	76.27	-119.44	-163.66	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash Interest Paid	43.52	43.52	49.02	15.78	24.24
Change in Working Capital	-63.09	-33.13	-29.07	-7.13	-22.26

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 5, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error